Please Wait

Applying Filters...

Drug Product Composition: Prestwick3_000541

Prestwick3_000541

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 6 USDMF, 5 CEP/COS, 1 KDMF, 5 NDC API, 6 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

93 FDF Dossiers, 32 FDA Orange Book, 54 Europe, 3 Canada, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.77%, SUSPENSION;TOPICAL - 0.77%, GEL;TOPICAL - 0.77% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;TOPICAL - 8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SHAMPOO;TOPICAL - 1%

RELATED EXCIPIENT COMPANIES

1 Seqens, 1 DKSH, 2 Nanjing Well Pharmaceutical, 2 Actylis, 8 BASF, 2 Corel Pharma Chem, 1 Finar, 1 Kerry, 2 Lubrizol Life Science Health, 1 Pluviaendo, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

11 Topical, 5 Solubilizers, 5 Parenteral, 3 Granulation, 3 Coating Systems & Additives, 2 Controlled & Modified Release, 2 Film Formers & Plasticizers, 2 Lubricants & Glidants, 2 Taste Masking, 2 Emulsifying Agents, 2 Thickeners and Stabilizers, 1 Direct Compression, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

4 NEWS #PharmaBuzz

4 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 66 Finished Drug Prices

MARKET PLACE

8 APIs

8 APIs

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 3 USP, 6 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21159 / DOSAGE - SHAMPOO;TOPICAL - 1%

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ciclopirox(UNII: 19W019ZDRJ) (ciclopirox - UNII:19W019ZDRJ)	ciclopirox	10mg in 0.96

Inactive Ingredients

Ingredient Name	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	Fougera Pharmaceuticals Inc.	Padagis Israel Pharmaceuticals Ltd
DISODIUM LAURETH SULFOSUCCINATE(D6DH1DTN7E)
LAURETH-2(D4D38LT1L5)
SODIUM CHLORIDE(451W47IQ8X)
SODIUM LAURETH-3 SULFATE(BPV390UAP0)
WATER(059QF0KO0R)

Drug Product Composition: Prestwick3_000541

Prestwick3_000541

Prestwick3_000541

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers

6 USDMF

5 CEP/COS

1 KDMF

5 NDC API

6 Listed Suppliers

$ API Reference Price

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FINISHED DOSAGE FORMULATIONS

93 FDF Dossiers

32 FDA Orange Book

54 Europe

3 Canada

4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.77%

SUSPENSION;TOPICAL - 0.77%

GEL;TOPICAL - 0.77% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;TOPICAL - 8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SHAMPOO;TOPICAL - 1%

RELATED EXCIPIENT COMPANIES

1 Seqens

1 DKSH

2 Nanjing Well Pharmaceutical

2 Actylis

8 BASF

2 Corel Pharma Chem

1 Finar

1 Kerry

2 Lubrizol Life Science Health

1 Pluviaendo

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

11 Topical

5 Solubilizers

5 Parenteral

3 Granulation

3 Coating Systems & Additives

2 Controlled & Modified Release

2 Film Formers & Plasticizers

2 Lubricants & Glidants

2 Taste Masking

2 Emulsifying Agents

2 Thickeners and Stabilizers

1 Direct Compression

1 Surfactant & Foaming Agents

DIGITAL CONTENT

4 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions

66 Finished Drug Prices

MARKET PLACE

8 APIs

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM

3 USP

6 Others

Filters

GEL;TOPICAL - 0.77% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;TOPICAL - 8% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons